Newswise — New York, NY (September 20, 2023) – A new study by researchers at the Icahn School of Medicine at Mount Sinai has unraveled the intricate molecular interplay between…
Read more Unveiling Asthma’s Molecular Secrets: How Blood Molecules Influence Airway ProcessesNewswise — New York, NY (August 24, 2023) — Asian Americans have significantly higher exposure than other ethnic or racial groups to PFAS, a family of thousands of…
Read more Mount Sinai Researchers Find Asian Americans to Have Significantly Higher Exposure to “Toxic Forever” ChemicalsBYLINE: Marlene Naanes Newswise — New York, NY (July 27, 2023) – Cigarette smokers have higher odds of tobacco dependence than those who vape or use a variety…
Read more Cigarette Smokers More at Risk for Tobacco Dependence Than Users of Smokeless Tobacco or Multiple Tobacco ProductsNewswise — New York, NY (February 17, 2023)—Immunotherapy after surgery increased bladder cancer patients’ chance of staying cancer-free compared to patients who received a placebo, according to clinical…
Read more Immunotherapy After Surgery Provides Significant, Durable Benefit for High-Risk Bladder PatientsNewswise — The Mount Sinai Phillips School of Nursing is celebrating two graduating 2022 classes, August and December, with a total of 150 students. The graduation ceremony will…
Read more Mount Sinai Phillips School of Nursing Welcomes the Classes of 2022 in Graduation CeremonyNewswise — New York, NY (December 10, 2022) — A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as…
Read more Experimental Cancer Therapy Shows Success in More Than 70 Percent of Patients in Global Clinical TrialsNewswise — Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the…
Read more New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term ResultsNewswise — New York, NY (November 2, 2022) – A novel metric that estimates our “burden,” or cumulative exposure, to a family of thousands of synthetic chemicals that…
Read more New Tool for Estimating People’s Total Exposure to Potentially Harmful Chemicals Is Developed
